1 / 12

Brian C.K. Au, M.D. University of Arizona – Department of Ophthalmology & University of Texas Medical Branch – Depar

Brian C.K. Au, M.D. University of Arizona – Department of Ophthalmology & University of Texas Medical Branch – Department of Ophthalmology ASCRS 2008 Annual Symposium Poster April 5-9, 2008. Financial Disclosure.

daniel_millan
Download Presentation

Brian C.K. Au, M.D. University of Arizona – Department of Ophthalmology & University of Texas Medical Branch – Depar

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Brian C.K. Au, M.D. University of Arizona – Department of Ophthalmology & University of Texas Medical Branch – Department of Ophthalmology ASCRS 2008 Annual Symposium Poster April 5-9, 2008

  2. Financial Disclosure • Brian C.K. Au, M.D. and co-authors do not have financial interests in any ophthalmic products or proprieties mentioned henceforth in this presentation. • Co-Authors (University of Arizona): • Jason W. Friday, M.S. IV • Stefano Lehman, M.D. • Robert W. Snyder, M.D., Ph.D. • Roxanna Ursea, M.D.

  3. Introduction • Dislocation of the corneal donor button is a common post-operative complication and cause of decreased visual acuity in Descemet’s Stripping with Endothelial Keratoplasty (DSEK). • Clinical Question: Is there a tool or substance that can: • 1) Reduce the rate of donor button dislocation after DSEK? • 2) Effectively accomplish # 1 without intraocular toxicity?

  4. Purpose and Setting • Purpose: • Part 1:To quantify the adhesive strength of Tisseel fibrin glue (Baxter, U.S.A.) when allowed to react in an in-vitro aqueous environment. • Part 2: To determine whether Tisseel is toxic when injected into the anterior chamber using a rabbit model. • Setting: • Experimentation and Analysis: University Laboratory, University of Arizona Department of Ophthalmology; Tucson, Arizona, USA. • Creation of Virtual Poster: University of Texas Medical Branch, Department of Ophthalmology and Visual Sciences; Galveston, Texas, USA.

  5. Methods – Part 1: Adhesive Strength • The adhesive strength of Tisseel fibrin glue was tested by using a Penscale tension device (My Weigh, U.S.A.), which measures the amount of force required to displace a donor button from a native cornea. Five measurements were taken with no adhesive for control, then 10 measurements were taken following injection of Tisseel between the opposing corneal surfaces submerged in balanced salt solution (BSS).

  6. Methods – Part 2: Intracameral Toxicity • The toxicity of Tisseel was tested using five New Zealand white rabbits, where 0.05 mL of both the fibrin and thrombin components were injected into the anterior chamber. Rabbits were monitored and graded, on a scale of 0-10, for signs of toxicity post-operatively for seven days using a Panoptic ophthalmoscope and a Tono-pen.

  7. Methods – Tension Device • 10 donor + 10 recipient New Zealand white rabbit clear corneas • Donor corneas (epithelium & Descemet’s stripped) adhered to concave glass lens by superglue • Recipients corneas (epithelium & Descemet’s stripped) adhered to convex epoxy lens by superglue • System submerged in BSS • Tisseel applied between donor and recipient corneal surfaces; then surfaces apposed in-vitro • After 5 minutes, tension applied and weight required to separate corneal surfaces was recorded

  8. Results • Part 1 – Adhesive Strength: The average force required to dislocate the donor button with no adhesive was found to be negligible at zero Newtons (N). The average force required to displace a donor button adhered with Tisseel was 0.15N (p<0.003). • Part 2 – Intracameral Toxicity: The toxicity study showed only mild inflammation on post-operative day one (average grade of 1.8) which decreased to an average grade of 0.8by day seven.

  9. Results – Part 1: Adhesive Strength • Table 1: Tension Device Readings. The initial weight of the glass lens with fixed recipient button, the weight at the moment of release, and the calculated difference yields the force of dislocation (F = ma) against gravity (a = 9.8m/s2). Experimental groups were separated into those corneas previously submerged in BSS (Group 1) and those that were used directly after preparation (Group 2).

  10. Results – Part 2: Intracameral Toxicity • Table 2. Rabbits were graded on 10 signs of inflammation using a Panoptic ophthalmoscope and a Tono-pen. Of note, rabbit #5 suffered a small puncture of the anterior capsule intraoperatively. While it was not removed from the experiment, this unintended trauma was taken into account when analyzing experimental results.

  11. Results (4) • Rabbit # 1 on post-operative day 7 – graded as 0/10.

  12. Conclusion • Part 1 – Adhesive Strength: Tisseel fibrin adhesive reacts in an aqueous environment and provides ample force to prevent donor corneal button dislocation following DSEK in an in-vitro model. • Part 2 – Intracameral Toxicity: Tisseel appears to be non-toxic when injected into anterior chambers of rabbits. Intracameral use of Tisseel may reduce the rate of donor button dislocation following DSEK.

More Related